ArticleBMC cancer2026

A single-center retrospective study of short-term efficacy and safety of blinatumomab in the treatment of high-risk acute lymphoblastic leukemia.

Yixuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.